Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients
NCT ID: NCT03845452
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
187 participants
OBSERVATIONAL
2016-01-01
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity.
* the relationship between voluntary muscle strength and mortality
* the relationship between voluntary muscle strength and physical activity
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Wasting in Hemodialysis Patient
NCT03583177
Assessment of Professional Practices in Muscle Rehabilitation of Chronic Hemodialysis
NCT04820140
Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.
NCT03998917
Efficiency of Combined Rehabilitation Programs Including Resistance and Endurance Exercises on Functional Capacities, Quality of Life and Daily Level of Activities in Hemodialysis Patients
NCT04538248
Quality of Life of Frail Aged Patients in Incremental Hemodialysis
NCT03782519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity.
* the relationship between voluntary muscle strength and mortality
* the relationship between voluntary muscle strength and physical activity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stable clinical condition (absence of infection, stroke or acute decompensation)
Exclusion Criteria
* history of renal transplantation
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Paul CRISTOL, Prof
Role: PRINCIPAL_INVESTIGATOR
CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Souweine JS, Pasquier G, Morena M, Patrier L, Rodriguez A, Raynal N, Ohresser I, Benomar R, Hayot M, Mercier J, Gouzi F, Cristol JP. Beyond sarcopenia: frailty in chronic haemodialysis patients. Clin Kidney J. 2024 Jun 29;17(7):sfae069. doi: 10.1093/ckj/sfae069. eCollection 2024 Jul.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL18_0447
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.